BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34629892)

  • 1. Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma.
    Li M; Yang B; Li X; Ren H; Zhang L; Li L; Li W; Wang X; Zhou H; Zhang W
    Int J Gen Med; 2021; 14():6261-6275. PubMed ID: 34629892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
    Wu X; Sui Z; Zhang H; Wang Y; Yu Z
    Front Oncol; 2020; 10():554759. PubMed ID: 33042838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.
    Cui Y; Cui Y; Gu R; Liu Y; Wang X; Bi L; Zhang S; Fan W; Tian F; Zhan Y; Zhang N; Xing Y; Cai L
    J Oncol; 2021; 2021():2659550. PubMed ID: 34987577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
    Wu X; Liu J; Zhu C; Ma M; Chen X; Liu Y; Xia N; Dong Q
    Med Sci Monit; 2020 Dec; 26():e927725. PubMed ID: 33328429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and analysis of the ceRNA network
    Yang Y; Zhang Y; Ding X; Ren Y; Wei B; Lin Z; Nie Y; Fan Y
    Ann Transl Med; 2021 Dec; 9(24):1757. PubMed ID: 35071451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma.
    Bai J; Zhu X; Zhang J; Bulin B
    Transl Cancer Res; 2021 Nov; 10(11):4652-4663. PubMed ID: 35116321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
    Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel circRNA-miRNA-mRNA Hub Regulatory Network in Lung Adenocarcinoma.
    Zuo H; Li X; Zheng X; Sun Q; Yang Q; Xin Y
    Front Genet; 2021; 12():673501. PubMed ID: 34306017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.
    Fan Q; Liu B
    Onco Targets Ther; 2018; 11():2453-2466. PubMed ID: 29760555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
    Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
    PeerJ; 2019; 7():e8024. PubMed ID: 31720124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
    Wang XJ; Gao J; Wang Z; Yu Q
    Front Cell Dev Biol; 2021; 9():641840. PubMed ID: 33681226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.